Proteingebundenen

Proteingebundenen is the German adjective meaning "protein-bound" and commonly refers to molecules—especially drugs, hormones, and metabolites—that are reversibly associated with proteins in biological fluids such as blood plasma. Binding typically occurs to abundant carrier proteins like albumin and alpha-1-acid glycoprotein, and the extent of binding is described by the fraction unbound (fu) or percent bound.

Protein binding influences pharmacokinetics and pharmacodynamics. Only the unbound fraction is freely diffusible, available for receptor interaction, metabolism, and renal filtration; high protein binding often prolongs apparent half-life and limits tissue distribution. Clinical consequences include altered drug effect in hypoalbuminemia, displacement interactions when two ligands compete for the same binding site, and changes in free concentration during illness or with co-administered drugs.

Binding can be characterized by affinity and capacity, and it is usually reversible. Measurement of unbound concentration is performed by methods such as equilibrium dialysis, ultrafiltration, or ultracentrifugation. Examples of clinically relevant protein-bound substances include many acidic drugs (e.g., warfarin, phenytoin), steroid hormones, bilirubin, and thyroid hormones.

Understanding proteingebundenen behavior is important in dosing, therapeutic drug monitoring, and interpreting laboratory values, since total concentration may not reflect the pharmacologically active unbound fraction. Factors affecting binding include protein concentration, pH, presence of competing ligands, and chemical properties of the ligand.